Top Stories
-
By studying the gaze of experts as they assess images of the eye, data scientist Kaveri Thakoor has improved AI methods for glaucoma detection and developed a new way to instruct trainees.
Topic
-
Columbia ophthalmologist Sonali Talsania explains how to safely watch the solar eclipse and what happens to the eyes if you look at the Sun.
-
Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.
Topic
-
Most people are familiar with melanoma as a skin cancer, but melanoma can impact the eyes as well. Brian Marr, MD, offers tips on how to protect your eyes.
Latest News
- July 12, 2023
A new study in mice, led by Columbia University researchers, suggests experimental eye drops may be more effective than injections for treatment of retinal vein occlusion, a major cause of blindness.
Topic
- April 5, 2022
If untreated, glaucoma can lead to irreversible vision loss. A Columbia screening program is finding more people with the disease than expected.
Topic
- January 31, 2022
Columbia research has found that simple nutrient supplements, vitamin B3 and pyruvate, may prevent glaucoma.
Topic
- August 9, 2021
An initiative led by a Columbia ophthalmologist seeks to improve the treatment of eye trauma, a serious but neglected condition second only to cataracts as the most common cause of visual impairment.
- June 14, 2021
Steven E. Rosenberg, MD, an expert in strabismus and pediatric ophthalmology, joins Columbia.
Topic
- April 27, 2021
Residents of some NYC public housing developments can get free vision screening and eye exams in their building as part of a new study led by Columbia University’s Department of Ophthalmology.
Topic
- March 22, 2021
Treatments for a rare retinal disease may be on the horizon after a new study identifies gene variants that cause a metabolic deficiency in the eye.
- March 9, 2021
A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration—a leading cause of blindness in the United States—is underway at Columbia and NewYork-Presbyterian.
Topic
- December 18, 2020
Simon John, PhD, professor of ophthalmology, has been awarded the Sanford and Susan Greenberg Visionary Prize for his research on glaucoma.
Topic
- August 3, 2020
New genetic and patient analyses suggest severe COVID is linked to overactive complement, one of the immune system’s oldest branches, and excess blood clotting.
Topic
